Patient number | Sampling time-point | CD4 count | 1-20% prevalence | >20% Prevalence |
---|---|---|---|---|
Patient 2 | Baseline | 64 | K65R | Â |
 | 11 Months | N/A (9 months: 110) | K65R, M184V, G190E |  |
 | 14 Months | 153 | K65R |  |
Patient 32 | Baseline | 271 | K65R, V90I | Â |
 | 7 Months | 384 | K65R | V90I |
 | 16 Months | N/A (19 months: 443) | K65R |  |
 | 24 Months | N/A | K65R |  |
Patient 42 | Baseline 1 (2008) | N/A | K65R | Â |
 | Baseline 2 (2009) | 362 | K65R, A98S, G190A |  |
Patient 45 | Baseline | 55 | K65R, A98S, K101E, K103E, K103N, K103R, M184I | V106I, E138A, G190A |
 | 8 Months | 216 | K65R, A98S, K101E, K103E, K103R | V106I, G190A |
 | 13 Months | 258 | K65R, K101E, K103E, K103N, K103R | V106I, E138A, G190A |
Patient 76 | Baseline | 118 | K65R, T69I, G190A, H221Y | V90I, A98S, Y181C |
 | 6 Months | N/A (8 months: 269) | K65R, K103N, H221Y | V90I, A98S, K103E, Y181C, H221Y |
 | 9 Months | N/A (12 months: 268) | K65R, V90I, K103E, G190A, H221Y | A98S, K103R, Y181C |